BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 31087627)

  • 1. Low dose sirolimus treatment for refractory tufted angioma and congenital kaposiform hemangioendothelioma, both with Kasabach-Merritt phenomenon.
    Mariani LG; Schmitt IR; Garcia CD; Kiszewski AE
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27810. PubMed ID: 31087627
    [No Abstract]   [Full Text] [Related]  

  • 2. Sirolimus as initial therapy for kaposiform hemangioendothelioma and tufted angioma.
    Wang H; Guo X; Duan Y; Zheng B; Gao Y
    Pediatr Dermatol; 2018 Sep; 35(5):635-638. PubMed ID: 29999213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirolimus therapy for children with problematic kaposiform haemangioendothelioma and tufted angioma.
    Tasani M; Ancliff P; Glover M
    Br J Dermatol; 2017 Dec; 177(6):e344-e346. PubMed ID: 28485019
    [No Abstract]   [Full Text] [Related]  

  • 4. Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon.
    Chiu YE; Drolet BA; Blei F; Carcao M; Fangusaro J; Kelly ME; Krol A; Lofgren S; Mancini AJ; Metry DW; Recht M; Silverman RA; Tom WL; Pope E
    Pediatr Blood Cancer; 2012 Nov; 59(5):934-8. PubMed ID: 22648868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon.
    Wang Z; Li K; Dong K; Xiao X; Zheng S
    Pediatr Blood Cancer; 2014 Aug; 61(8):1518-9. PubMed ID: 24482015
    [No Abstract]   [Full Text] [Related]  

  • 6. Identical Presentation of Scapular Osteolysis in Two Patients with Thoracic Kaposiform Hemangioendothelioma.
    Alonso Arroyo V; Lopez-Gutierrez JC; Martinez R; Fernandez-Pineda I
    Pediatr Dermatol; 2017 May; 34(3):e146-e149. PubMed ID: 28382716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus ointment for the treatment of superficial kaposiform hemangioendothelioma and tufted angioma.
    Zhang X; Yang K; Chen S; Ji Y
    J Dermatol; 2019 Oct; 46(10):898-901. PubMed ID: 31373046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: from vincristine to sirolimus.
    Jahnel J; Lackner H; Reiterer F; Urlesberger B; Urban C
    Klin Padiatr; 2012 Oct; 224(6):395-7. PubMed ID: 23070861
    [No Abstract]   [Full Text] [Related]  

  • 9. Sirolimus for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon in Two Infants.
    Wang Y; Kong L; Sun B; Cui J; Shen W
    J Craniofac Surg; 2020 Jun; 31(4):1074-1077. PubMed ID: 32176003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus.
    Cashell J; Smink GM; Helm K; Xavier F
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27305. PubMed ID: 30070028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retroperitoneal kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon and obstructive jaundice: A retrospective series of 3 patients treated with sirolimus.
    Yao W; Li K; Wang Z; Dong K; Zheng S
    Pediatr Dermatol; 2020 Jul; 37(4):677-680. PubMed ID: 32212177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful Management of Pancreatic Kaposiform Hemangioendothelioma With Sirolimus: Case Report and Literature Review.
    Wang C; Li Y; Xiang B; Li F; Chen S; Li L; Ji Y
    Pancreas; 2017; 46(5):e39-e41. PubMed ID: 28426496
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of Kaposiform hemangioendothelioma with everolimus.
    Uno T; Ito S; Nakazawa A; Miyazaki O; Mori T; Terashima K
    Pediatr Blood Cancer; 2015 Mar; 62(3):536-8. PubMed ID: 25306933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Image Gallery: Kaposiform haemangioendothelioma.
    Moscarella E; Ametrano O; Diplomatico M; De Chiara C; Capasso M; Errico ME; Picciocchi R
    Br J Dermatol; 2017 Jun; 176(6):e124. PubMed ID: 28581217
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of Refractory Pediatric Kaposiform Hemangioendothelioma With Sirolimus and Aspirin.
    MacFarland SP; Sullivan LM; States LJ; Bailey LC; Balamuth NJ; Womer RB; Olson TS
    J Pediatr Hematol Oncol; 2018 May; 40(4):e239-e242. PubMed ID: 29240034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An intermediate vascular tumour between kaposiform hemangioendothelioma and tufted angioma with regression of the skin lesion.
    Makino T; Ishida W; Hamashima T; Mizawa M; Sasahara M; Shimizu T
    Eur J Dermatol; 2017 Apr; 27(2):175-176. PubMed ID: 27882874
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapidly enlarging "bruise" on the back of an infant. Kaposiform hemangioendothelioma complicated by Kasabach-Merritt syndrome.
    Chan S; Cassarino DS
    JAMA Dermatol; 2013 Nov; 149(11):1337-8. PubMed ID: 24005816
    [No Abstract]   [Full Text] [Related]  

  • 18. Sirolimus for treatment of Kaposiform haemangioendothelioma with Kasabach-Merritt phenomenon: a retrospective cohort study.
    Zhang G; Chen H; Gao Y; Liu Y; Wang J; Liu XY
    Br J Dermatol; 2018 May; 178(5):1213-1214. PubMed ID: 29388191
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment of Kasabach-Merritt phenomenon arising from Kaposiform hemangioendothelioma by sirolimus.
    Wang Z; Li K; Dong K; Xiao X; Zheng S
    J Pediatr Hematol Oncol; 2015 Jan; 37(1):72-3. PubMed ID: 24309604
    [No Abstract]   [Full Text] [Related]  

  • 20. Kaposiform Hemangioendothelioma: Multifocal Involvement, Chylothorax, and Kasabach-Merritt Phenomenon.
    Das A; Bansal D; Chatterjee D; Das A
    J Pediatr Hematol Oncol; 2017 Mar; 39(2):153-154. PubMed ID: 27820128
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.